Swisspreneur Show

Exploring the revolutionary impact of AI with ChatGPT, AI companies challenging tech giants like Google, ethical challenges in AI, Swiss supercomputer innovations, and the role of government regulation in eradicating biases in AI models.

Exploring social impact entrepreneurship for migrants in Switzerland, funding for SINGA, Swiss fear of failure, and knowing when to move on. Seraina Soldner shares insights on empowering refugees through entrepreneurship, eligibility criteria, challenges faced by migrants, risk-taking in Switzerland, and personal growth in career transitions. Discover innovative healthcare startups, facing fear, team dynamics, and personal reflections on motivation and career.

The podcast discusses illegal work in Switzerland, with 30-60% of domestic helpers not registered. Cleaners benefit from working with quitt, earning higher salaries. quitt has over 20,000 customers and plans to expand to Germany in 2023. The episode also explores challenges faced by startups in Switzerland's deep tech ecosystem and the ethical employment practices advocated by quitt.

Timestamps: 2:20 - The Swiss ecosystem in the last 10 years  11:05 - Why are tradesales down?  19:19 - The rise of the Romandie  21:35 - How Switzerland compares to other startup hubs  28:17 - Going public in the US vs CH About Stefan Kyora & Thomas Heimann: Stefan Kyora is editor-in-chief at startupticker.ch, the leading Swiss news portal for startups, supporters, innovators and investors, and holds a PhD in Philosophy and Business Ethics from the University of Konstanz. Thomas Heimann is a deputy general secretary at SECA, the Swiss Private Equity & Corporate Finance Association, and the Head Risk Management & Equity Analyst at HBM Partners AG, a Swiss healthcare investor. The two of them co-authored the 2023 Swiss Venture Capital Report, which you can download for free here. During their chat with Silvan, they summarized the report’s findings, as well as the conclusions we can draw from them: It is still difficult for Swiss companies to raise large rounds from Swiss investors. This isn’t because we don’t have plenty of VC funds, or because those funds don’t invest in Swiss companies — there are many Swiss VC funds with at least 50% of their capital allocated to Swiss startups, but these are small funds investing small amounts. The total amount of funds invested in Swiss startups (both foreign and Swiss) went down in 2023 for the first time in a while. After a 10 year boom, this is to be expected, and can easily be explained if we take the unfavorable international conjuncture into account. Comparatively, Switzerland is still doing well, and is quite stable. Tradesales are also down in Switzerland, both when it comes to Swiss buyers and to foreign buyers. Thomas Heimann speculates they may increase, since larger, later stage fundraising rounds are becoming more rare. Fintech, cleantech and biotech are the most popular and well-funded sectors in Switzerland. Don’t forget to give us a follow on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, so you can always stay up to date with our latest initiatives. That way, there’s no excuse for missing out on live shows, weekly giveaways or founders' dinners.

From growing a company from 2 to 220 employees to a founder's motivation and a CEO's evolving role, Cris Grossmann shares valuable lessons learned during his time at beekeeper. He emphasizes the importance of staying true to company values, even in challenging times, and discusses the mission of solving tech issues for frontline workers. The podcast also explores the evolution of business strategy and the CEO's strengths and challenges in leadership roles.

Timestamps: 2:40 - Samuel’s biggest mistake 8:01 - Expanding to the US instead of DACH  10:10 - Growing your headcount 13:37 - OKRs at Scandit  18:38 - Staying healthy and sane as a founder About Samuel Mueller: Samuel Mueller is the co-founder and CEO at Scandit, the leading technology platform for mobile computer vision and augmented reality (AR) solutions for enterprises. He holds a PhD in Computer Science and Temporal Logics from ETH Zurich. Together with Christian Floerkermeier and Christof Roduner, he created Scandit in 2009. Their goal with Scandit was to create a bridge between real world objects and the digital information available about them. Barcodes were then the natural entry points, especially at a time when phone cameras were just starting to become ubiquitous. Scandit runs a subscription-based model which allows customers to “go as they grow”, meaning the bigger they get, the more Scandit services they can accrue. It's also a very high margin business, because a lot of the heavy lifting, the computer vision magic, is happening on the user devices, so there’s no distinct cloud need. Don’t forget to give us a follow on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, so you can always stay up to date with our latest initiatives. That way, there’s no excuse for missing out on live shows, weekly giveaways or founders' dinners.

Redeem your EUR 75 bonus at Splint Invest with code Dali24: https://splintinvest.onelink.me/ZGYb/swppod Timestamps: 5:20 - Going from researcher to entrepreneur  8:57 - How bacteria kills cancer 15:14 - Proof of concept in biotech 17:56 - Avenues after a tradesale  24:13 - Entrepreneurship and motherhood About Ana Montalban-Arques: Ana Montalban-Arques is co-founder and CEO of Recolony, a biotech startup developing a bacteria-based oral therapy to treat cancer. She holds a PhD in Medicine from the Medizinische Universität Graz (Austria) and previously worked at hospitals in Spain and Switzerland before starting Recolony in 2022. In the past few years, scientists have been made aware of the extent to which our gut microbiome influences our health. Considering we’ve been evolving alongside these bacterias for thousands upon thousands of years, it can be safely said that we’ve developed a symbiotic bond: the state of our microbiome influences our immune system and can even cause (or prevent) certain inflammatory diseases. Recolony’s team took this research one step further when they found a deficiency in a certain type of bacteria in colorectal cancer patients, and hypothesized whether providing patients with the missing bacteria could help treat their disease. Animal tests showed that this specific bacteria can not only prevent tumors but also treat them once they are already in existence, and that it works not only with colorectal cancer but other sorts of cancers as well, regardless of the fact that the bacteria is in the gut and the tumor may be somewhere completely different in the body. This is because the bacteria produces molecules which travel through the bloodstream and activate an immune response to fight the tumors. Recolony is a spin-off company from the University of Zurich that started as a research project in the Department of Gastroenterology and Hepatology at the University Hospital Zurich. So far the team has received CHF160K in grant money. Don’t forget to give us a follow on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, so you can always stay up to date with our latest initiatives. That way, there’s no excuse for missing out on live shows, weekly giveaways or founders' dinners.

Timestamps: 8:13 - Why Nestlé isn’t doing what they’re doing 11:50 - Why the timing was right for new coffee 18:00 - Straying from the classical Swiss path  23:18 -  Developing the nonormal MVP with partners  27:00 - Fundraising through the Swisspreneur Syndicate About Philippe Greinacher & Alexander Häberlin: Philippe Greinacher is the co-founder and CEO of nonormal, a startup producing sustainable, high-quality coffee for outdoor consumption — that comes in a tube! He holds a BA in Business Administration from the Business School of Lausanne, and has more than 10 years of experience in business development, sales and partnerships working for Ringier, Ogilvy & Mather, Meltwater, PriceHubble in Africa and Europe. Alexander Häberlin is the co-founder and CMO of nonormal. He holds an MA in Marketing Management/Business Development from the University of Applied Sciences of Northwestern Switzerland and worked for many years in the design field helping various international companies such as Sennheiser, Meta, Leica or BAT. nonormal partnered with a food development contractor to create coffee that is sustainable, organic, has great taste, is vegan and Swiss-made, and comes from a tube, allowing all outdoor enthusiasts to get a cup of coffee whenever they feel like it. So far they’ve got 15K pre-orders coming from 10 countries, CHF 100K from angel investors in Switzerland and the US, and commitments from retail distributors based in Switzerland and abroad. They’re now raising CHF 500K in a convertible note, part of which is being raised through the Swisspreneur Syndicate. Click here to learn more about the deal. Don’t forget to give us a follow on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Linkedin⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, so you can always stay up to date with our latest initiatives. That way, there’s no excuse for missing out on live shows, weekly giveaways or founders' dinners.

Holger Seim, co-founder and former CEO of Blinkist, shares the story behind the mobile-first microlearning app that condenses long-form content into 15-minute reads or listens. Topics discussed include finding a solid idea, revenue split between B2C and B2B markets, user acquisition and retention strategies, data-driven approach to relevance, customer acquisition costs and scaling, and the process of selling Blinkist and integrating with a new organization.

Nicolas Egger, co-founder of Poinz and Aepsy, discusses his journey from footballer to entrepreneur. Topics include the emotional toll of startups, sorting out shares, getting good psychologists on Aepsy, and going B2C first, then B2B.